Risk Stratification Schemes dalam Mendeteksi Stroke pada Pasien Atrial Fibrillation

Risk Stratification Schemes in Detecting Stroke in Atrial Fibrillation Patients

  • Andi Muhammad Fiqri Muslih Djaya Mahasiswa program Studi Magister Ilmu Keperawatan Universitas Hasanuddin
  • Elly L.Sjattar Program Studi Magister Ilmu Keperawatan Universitas Hasanuddin
  • Abdul Majid Program Studi Magister Ilmu Keperawatan Universitas Hasanuddin
DOI: https://doi.org/10.56338/pjkm.v11i2.2143
Keywords: Skema Stratifikasi, Risiko, Fibrilasi Atrium

Abstract

Tidak selalu memiliki tingkat stroke 'risiko rendah'. Sementara itu, skor CHA2DS2-VASc = 0 dengan jelas mengidentifikasi pasien 'berisiko rendah'. Kesimpulan Penggunaan skor CHA2DS2-VASc secara signifikan meningkatkan klasifikasi AF Atrial fibrillation (AF) merupakan salah satu gangguan irama jantung (aritmia). AF memainkan peran utama dalam meningkatkan morbiditas penyakit kardiovaskular dan serebrovaskular. Menurut Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI), AF erat kaitannya dengan penyakit kardiovaskular lainnya seperti hipertensi, gagal jantung, penyakit jantung koroner (PJK), hipertiroid, diabetes mellitus, obesitas, penyakit jantung bawaan seperti atrial septal defect, kardiomiopati, penyakit ginjal kronis. (CKD), dan penyakit paru obstruktif kronik (PPOK). Tujuan dari penelitian ini adalah untuk mengidentifikasi skema stratifikasi risiko kontemporer: CHADS2 dan CHA2DS2-VASc. Desain penelitian ini adalah studi kepustakaan. Basis data yang digunakan untuk mencari artikel antara lain Wiley Online Library, PubMed, dan Gray Literature. Pertanyaan penelitian disusun menggunakan metode PIRD dan pencarian kata kunci didasarkan pada database pada Persyaratan MESH. Studi kami mengidentifikasi dua instrumen ini: Skor CHA2DS2-VASc dapat meningkatkan stratifikasi risiko stroke. A CHADS2 = 0 skor pasien dengan risiko stroke rendah dan sedang, dibandingkan dengan skor CHADS2 yang umum digunakan. Pada pasien ACS yang diobati dengan clopidogrel setelah PCI, skor CHADS2 dan CHA2DS2-VASc yang tinggi berkorelasi dengan HPR dan skor yang lebih rendah berkorelasi dengan OPR, secara langsung berkaitan dengan kejadian POAF setelah operasi katup dan skor yang lebih tinggi sangat memprediksi POAF.

References

1. Pistoia F, Sacco S, Tiseo C, Degan D, Ornello R, Carolei A. The epidemiology of atrial fibrillation and stroke. Cardiol Clin. 2016;34(2):255–68.
2. Members AF, Camm AJ, Lip GYH, De Caterina R, Savelieva I, Atar D, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–47.
3. Wolf PA, Benhamin EJ, Belanger AJ, Kannel WB, Levy D, D’Agostino RB. Secular trends in the prevalence of atrial fibrillation: the Framingham Study. Am Heart J. 1996;131(4):790–5.
4. Camm AJ, Lip GY. De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG); 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Hear J. 2012;33:2719–47.
5. Yuniadi Y, Tondas AE, Hanafy DA, Hermanto DY, Maharani E, Munawar M, et al. Pedoman tata laksana fibrilasi atrium. Perhimpun Dr Spes Kardiovask Indones. 2014;1–36.
6. Chen Y-L, Wang H-T, Chen H-C, Liu W-H, Hsueh S, Chung W-J, et al. A risk stratification scoring system for new-onset atrial fibrillation after ischemic stroke: A National cohort study. Medicine (Baltimore). 2020;99(27).
7. Brandes A, Crijns HJGM, Rienstra M, Kirchhof P, Grove EL, Pedersen KB, et al. Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure. EP Eur. 2020;22(8):1149–61.
8. Barkas F, Elisaf M, Korantzopoulos P, Tsiara S, Liberopoulos E. The CHADS2 and CHA2DS2-VASc scores predict atrial fibrillation in dyslipidemic individuals: role of incorporating low high-density lipoprotein cholesterol levels. Int J Cardiol. 2017;241:194–9.
9. Tomasdottir M, Friberg L, Hijazi Z, Lindbäck J, Oldgren J. Risk of ischemic stroke and utility of CHA2DS2‐VASc score in women and men with atrial fibrillation. Clin Cardiol. 2019;42(10):1003–9.
10. Olesen JB, Torp-Pedersen C, Hansen ML, Lip GYH. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: a nationwide cohort study. Thromb Haemost. 2012;107(06):1172–9.
11. Asher E, Abu-Much A, Bragazzi NL, Younis A, Younis A, Masalha E, et al. CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome. J Cardiol. 2021;77(4):375–9.
12. Xiao X, Wu Z-C, Chou K-C. A multi-label classifier for predicting the subcellular localization of gram-negative bacterial proteins with both single and multiple sites. PLoS One. 2011;6(6):e20592.
13. Gage BF, Yan Y, Milligan PE, Waterman AD, Culverhouse R, Rich MW, et al. Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J. 2006;151(3):713–9.
14. Keogh C, Wallace E, Dillon C, Dimitrov BD, Fahey T. Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke. Thromb Haemost. 2011;106(09):528–38.
15. Livneh N, Braeken D, Drozdinsky G, Gafter-Gvili A, Seelig J, Rozovski U, et al. Anticoagulation in patients with atrial fibrillation, thrombocytopenia and hematological malignancy. J Thromb Thrombolysis. 2021;1–7.
16. Jeong H, Hong BY, Kim JS, Park J, Jung JY, Lim SH. Hemoptysis in Quadriplegia with Atrial Fibrillation Who Was Taking Edoxaban: a Case Report. Brain & Neurorehabilitation. 2020;14.
17. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Endorsed by the European Stroke Organisation (ESO). Eur Heart J. 2016;37(38):2893–962.
18. Maheshwari A, Norby FL, Roetker NS, Soliman EZ, Koene RJ, Rooney MR, et al. Refining prediction of atrial fibrillation–related stroke using the P2-CHA2DS2-VASc score: ARIC and MESA. Circulation. 2019;139(2):180–91.
19. Lin L-Y, Lee C-H, Yu C-C, Tsai C-T, Lai L-P, Hwang J-J, et al. Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation—a nation wide database analysis. Atherosclerosis. 2011;217(1):292–5.
Published
2021-12-12
Issue
Vol. 11 No. 2: DESEMBER 2021
Section
Original Articles

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-Non Commercial License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

The content of this website is licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) license. Creative Commons License